Granahan Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-168,424
| Closed | -$1.41M | – | 194 |
|
|
2021
Q4 | $1.41M | Sell |
168,424
-5,751
| -3% | -$48K | 0.03% | 180 |
|
|
2021
Q3 | $1.29M | Sell |
174,175
-183,642
| -51% | -$1.36M | 0.02% | 183 |
|
|
2021
Q2 | $2.43M | Buy |
357,817
+18,848
| +6% | +$128K | 0.05% | 177 |
|
|
2021
Q1 | $3.48M | Sell |
338,969
-61,044
| -15% | -$627K | 0.07% | 157 |
|
|
2020
Q4 | $2.8M | Sell |
400,013
-71,609
| -15% | -$501K | 0.06% | 163 |
|
|
2020
Q3 | $3.85M | Sell |
471,622
-44,126
| -9% | -$360K | 0.13% | 123 |
|
|
2020
Q2 | $3.56M | Buy |
515,748
+251,609
| +95% | +$1.74M | 0.13% | 122 |
|
|
2020
Q1 | $1.26M | Buy |
264,139
+141,857
| +116% | +$674K | 0.07% | 158 |
|
|
2019
Q4 | $1.07M | Sell |
122,282
-630
| -0.5% | -$5.5K | 0.05% | 157 |
|
|
2019
Q3 | $409K | Buy |
122,912
+6,832
| +6% | +$22.7K | 0.02% | 174 |
|
|
2019
Q2 | $575K | Sell |
116,080
-9,453
| -8% | -$46.8K | 0.03% | 174 |
|
|
2019
Q1 | $778K | Sell |
125,533
-5,860
| -4% | -$36.3K | 0.04% | 178 |
|
|
2018
Q4 | $443K | Sell |
131,393
-3,887
| -3% | -$13.1K | 0.03% | 179 |
|
|
2018
Q3 | $879K | Buy |
135,280
+3,688
| +3% | +$24K | 0.05% | 182 |
|
|
2018
Q2 | $1.01M | Buy |
131,592
+11,007
| +9% | +$84.3K | 0.06% | 183 |
|
|
2018
Q1 | $2.7M | Buy |
120,585
+2,525
| +2% | +$56.4K | 0.19% | 138 |
|
|
2017
Q4 | $1.51M | Buy |
+118,060
| New | +$1.51M | 0.12% | 155 |
|